Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | December 11, 2024 |
| PDB ID ▲ | UniProt ID | Title | Descriptor |
|---|---|---|---|
| 6OPO | B3UES2 | Symmetric model of CD4- and 17-bound B41 HIV-1 Env SOSIP in complex with DDM | |
| 6OPO | B3UEZ6 | Symmetric model of CD4- and 17-bound B41 HIV-1 Env SOSIP in complex with DDM | |
| 6OPO | P01730 | Symmetric model of CD4- and 17-bound B41 HIV-1 Env SOSIP in complex with DDM | |
| 6OPO | 6OPO | Symmetric model of CD4- and 17-bound B41 HIV-1 Env SOSIP in complex with DDM | |
| 6OPP | B3UES2 | Asymmetric model of CD4- and 17-bound B41 HIV-1 Env SOSIP in complex with DDM | |
| 6OPP | B3UEZ6 | Asymmetric model of CD4- and 17-bound B41 HIV-1 Env SOSIP in complex with DDM | |
| 6OPP | P01730 | Asymmetric model of CD4- and 17-bound B41 HIV-1 Env SOSIP in complex with DDM | |
| 6OPP | 6OPP | Asymmetric model of CD4- and 17-bound B41 HIV-1 Env SOSIP in complex with DDM | |
| 6OPQ | B3UES2 | CD4- and 17-bound HIV-1 Env B41 SOSIP frozen with LMNG | |
| 6OPQ | B3UEZ6 | CD4- and 17-bound HIV-1 Env B41 SOSIP frozen with LMNG | |
| 6OPQ | P01730 | CD4- and 17-bound HIV-1 Env B41 SOSIP frozen with LMNG | |
| 6OPQ | 6OPQ | CD4- and 17-bound HIV-1 Env B41 SOSIP frozen with LMNG | |
| 6OQ7 | M4NKV9 | Structure of the GTD domain of Clostridium difficile toxin B in complex with VHH E3 | |
| 6OQ7 | 6OQ7 | Structure of the GTD domain of Clostridium difficile toxin B in complex with VHH E3 | |
| 6OR2 | A0QP27 | MmpL3 is a lipid transporter that binds trehalose monomycolate and phosphatidylethanolamine | |
| 6OR3 | O59952 | Structure of an Acyl Intermediate of Thermomyces Lanuginosa Lipase With Palmitic Acid in an Orthorhombic Crystal | |
| 6OR4 | A0A0H2US78 | Crystal structure of SpGH29 | |
| 6ORF | A0A0H2US78 | Crystal structure of SpGH29 | |
| 6ORH | A0A0H2US78 | Crystal structure of SpGH29 | |
| 6ORM | 6ORM | Crystal Structure of Peruvianin-I (Cysteine peptidase from Thevetia peruviana latex) | |
| 6ORN | 6ORN | Modified BG505 SOSIP-based immunogen RC1 in complex with the elicited V3-glycan patch bNAb 10-1074 | |
| 6ORO | 6ORO | Modified BG505 SOSIP-based immunogen RC1 in complex with the elicited V3-glycan patch antibody Ab874NHP | |
| 6ORP | 6ORP | Modified BG505 SOSIP-based immunogen RC1 in complex with the elicited V3-glycan patch antibody Ab897NHP | |
| 6ORQ | 6ORQ | Modified BG505 SOSIP-based immunogen RC1 in complex with the elicited V3-glycan patch antibody Ab275MUR | |
| 6OS0 | P0ABE7 | Structure of synthetic nanobody-stabilized angiotensin II type 1 receptor bound to angiotensin II | |
| 6OS0 | P30556 | Structure of synthetic nanobody-stabilized angiotensin II type 1 receptor bound to angiotensin II | |
| 6OS0 | P01019 | Structure of synthetic nanobody-stabilized angiotensin II type 1 receptor bound to angiotensin II | |
| 6OS0 | 6OS0 | Structure of synthetic nanobody-stabilized angiotensin II type 1 receptor bound to angiotensin II | |
| 6OS2 | P0ABE7 | Structure of synthetic nanobody-stabilized angiotensin II type 1 receptor bound to TRV026 | |
| 6OS2 | P30556 | Structure of synthetic nanobody-stabilized angiotensin II type 1 receptor bound to TRV026 | |
| 6OS2 | 6OS2 | Structure of synthetic nanobody-stabilized angiotensin II type 1 receptor bound to TRV026 | |
| 6OSR | C7S1Y2 | Crystal structure of Influenza hemagglutinin from strain A/Melbourne/1/1946(H1N1) | |
| 6OSY | Q2N0S6 | Cryo-EM structure of vaccine-elicited antibody 0PV-a.01 in complex with HIV-1 Env BG505 DS-SOSIP and antibodies VRC03 and PGT122 | |
| 6OSY | 6OSY | Cryo-EM structure of vaccine-elicited antibody 0PV-a.01 in complex with HIV-1 Env BG505 DS-SOSIP and antibodies VRC03 and PGT122 | |
| 6OSZ | O59952 | High Resolution Structure of the Monoclinic Form of Thermomyces Lanuginosa Lipase Complexed with Its Catalytic Products | |
| 6OT1 | 6OT1 | Cryo-EM structure of vaccine-elicited antibody 0PV-b.01 in complex with HIV-1 Env BG505 DS-SOSIP and antibodies VRC03 and PGT122 | |
| 6OT1 | Q2N0S6 | Cryo-EM structure of vaccine-elicited antibody 0PV-b.01 in complex with HIV-1 Env BG505 DS-SOSIP and antibodies VRC03 and PGT122 | |
| 6OUS | P03420 | Structure of fusion glycoprotein from human respiratory syncytial virus | |
| 6OUS | M1E1E4 | Structure of fusion glycoprotein from human respiratory syncytial virus | |
| 6OUS | 6OUS | Structure of fusion glycoprotein from human respiratory syncytial virus | |
| 6OZ2 | A0A0M3KKW9 | Crystal structure of the broadly neutralizing antibody N49P6 Fab in complex with HIV-1 Clade A/E strain 93TH057 gp120 core. | |
| 6OZ2 | 6OZ2 | Crystal structure of the broadly neutralizing antibody N49P6 Fab in complex with HIV-1 Clade A/E strain 93TH057 gp120 core. | |
| 6OZ3 | A0A0M3KKW9 | Crystal structure of broadly neutralizing antibody N49P9.1 Fab in complex with HIV-1 Clade A/E strain 93TH057 gp120 core | |
| 6OZ3 | 6OZ3 | Crystal structure of broadly neutralizing antibody N49P9.1 Fab in complex with HIV-1 Clade A/E strain 93TH057 gp120 core | |
| 6OZ4 | Q2N0S6 | Crystal structure of broadly neutralizing antibody N49P6 Fab in complex with HIV-1 BG505 SOSIP.664 Env trimer ectodomain. | |
| 6OZ4 | 6OZ4 | Crystal structure of broadly neutralizing antibody N49P6 Fab in complex with HIV-1 BG505 SOSIP.664 Env trimer ectodomain. | |
| 6OZ9 | A0A0E3H7K0 | Ebola virus glycoprotein in complex with EBOV-520 Fab | |
| 6OZ9 | A0A0E3H7K2 | Ebola virus glycoprotein in complex with EBOV-520 Fab | |
| 6OZ9 | 6OZ9 | Ebola virus glycoprotein in complex with EBOV-520 Fab | |
| 6OZC | Q2N0S6 | BG505 SOSIP.664 with 2G12 Fab2 |
